MedPath

Measuring onset of neuromuscular monitoring at adductor pollicis and trapezius muscle as indicator of favourable intubating conditions

Phase 4
Not yet recruiting
Conditions
Medical and Surgical,
Registration Number
CTRI/2023/08/056753
Lead Sponsor
MAX SUPER SPECIALITY HOSPITAL
Brief Summary

This is a randomized, prospective clinical trial comparing onset of neuromuscular block at adductor pollicis and trapezius muscle after injection of rocuronium in 70 ASA I-II patients undergoing general anaesthesia. The purpose of the trial is to look for favourable intubating conditions after rocuronium injection.

Aim of this study is to evaluate trapezius muscle as indicator of favourable intubating conditions after neuromuscular blockage compared to adductor pollicis muscle.During intubation, inadequate muscle relaxation can lead to increased sympathetic stimulation and poor CL grade. Hence finding the adequate dosage of neuromuscular blocking agents by using peripheral nerve stimulators at different  muscle groups can lead to better intubating conditions.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
70
Inclusion Criteria
  • ASA grade I,II 2.
  • Patients giving consent for the study.
Exclusion Criteria
  • Patients refusing to give consent for the study 2.
  • ASA Physical Status Classification ≥ III 3.
  • Patients requiring an awake intubation 4.
  • Allergies to drugs administered during the study 5.
  • Neuromuscular disease.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
onset time of neuromuscular block at the APM & trapezius muscle for endotracheal intubation5 MINUTES
Secondary Outcome Measures
NameTimeMethod
To assess for acceptable intubation conditions using CL grade, vocal cord & diaphragmatic movements during laryngoscopy5 MINUTES

Trial Locations

Locations (1)

Max Super Specialty Hospital, Mohali

🇮🇳

Chandigarh, CHANDIGARH, India

Max Super Specialty Hospital, Mohali
🇮🇳Chandigarh, CHANDIGARH, India
DrAmandeep Kaur
Principal investigator
8146356800
amandeepkaur16894@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.